164 related articles for article (PubMed ID: 14686493)
1. Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma.
Terpos E; Samarkos M; Meletis C; Apostolidou E; Tsironi M; Korovesis K; Mavrogianni D; Viniou N; Meletis J
Int J Hematol; 2003 Nov; 78(4):344-8. PubMed ID: 14686493
[TBL] [Abstract][Full Text] [Related]
2. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
[TBL] [Abstract][Full Text] [Related]
3. Detection of CD55- and/or CD59-deficient red cell populations in patients with plasma cell dyscrasias.
Meletis J; Terpos E; Samarkos M; Meletis C; Apostolidou E; Komninaka V; Korovesis K; Anargyrou K; Benopoulou O; Mavrogianni D; Variami E; Viniou N; Konstantopoulos K
Int J Hematol; 2002 Jan; 75(1):40-4. PubMed ID: 11843289
[TBL] [Abstract][Full Text] [Related]
4. Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.
Terpos E; Viniou N; de la Fuente J; Meletis J; Voskaridou E; Karkantaris C; Vaiopoulos G; Palermos J; Yataganas X; Goldman JM; Rahemtulla A
Eur J Haematol; 2003 Jan; 70(1):34-42. PubMed ID: 12631257
[TBL] [Abstract][Full Text] [Related]
5. Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes.
Meletis J; Terpos E; Samarkos M; Meletis C; Apostolidou E; Komninaka V; Korovesis K; Mavrogianni D; Boutsis D; Variami E; Viniou N; Konstantopoulos K; Loukopoulos D
Hematol J; 2001; 2(1):33-7. PubMed ID: 11920231
[TBL] [Abstract][Full Text] [Related]
6. Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma.
Terpos E; Politou M; Szydlo R; Nadal E; Avery S; Olavarria E; Kanfer E; Goldman JM; Apperley JF; Rahemtulla A
Leukemia; 2004 Aug; 18(8):1420-6. PubMed ID: 15215875
[TBL] [Abstract][Full Text] [Related]
7. Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS).
Politou M; Terpos E; Anagnostopoulos A; Szydlo R; Laffan M; Layton M; Apperley JF; Dimopoulos MA; Rahemtulla A
Br J Haematol; 2004 Sep; 126(5):686-9. PubMed ID: 15327520
[TBL] [Abstract][Full Text] [Related]
8. Detection of paroxysmal nocturnal hemoglobinuria-phenotype in patients with chronic lymphocytic leukemia and multiple myeloma.
Varma S; Varma N; Reddy VV; Naseem S; Bose P; Malhotra P
Indian J Pathol Microbiol; 2012; 55(2):206-10. PubMed ID: 22771645
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic discrepancies between granulocytic and erythroid lineages in peripheral blood of patients with paroxysmal nocturnal haemoglobinuria.
Pakdeesuwan K; Wanachiwanawin W; Siripanyaphinyo U; Pattanapanyasat K; Wilairat P; Issaragrisil S
Eur J Haematol; 2000 Jul; 65(1):8-16. PubMed ID: 10914934
[TBL] [Abstract][Full Text] [Related]
10. Detection of "PNH red cell" populations in hematological disorders using the Sephacryl Gel Test micro typing system.
Meletis J; Michali E; Samarkos M; Konstantopoulos K; Meletis C; Terpos E; Tsimberidou A; Chandrinou E; Viniou N; Rombos Y; Pangalis GA; Yataganas X; Loukopoulos D
Leuk Lymphoma; 1997 Dec; 28(1-2):177-82. PubMed ID: 9498717
[TBL] [Abstract][Full Text] [Related]
11. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
Mountzios G; Dimopoulos MA; Bamias A; Papadopoulos G; Kastritis E; Syrigos K; Pavlakis G; Terpos E
Acta Oncol; 2007; 46(2):221-9. PubMed ID: 17453373
[TBL] [Abstract][Full Text] [Related]
12. The combination of lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation: final results on 205 patients of the Greek myeloma study group.
Terpos E; Christoulas D; Kastritis E; Katodritou E; Papatheodorou A; Pouli A; Kyrtsonis MC; Michalis E; Papanikolaou X; Gkotzamanidou M; Koulieris E; Gavriatopoulou M; Zervas K; Dimopoulos MA;
Am J Hematol; 2014 Jan; 89(1):34-40. PubMed ID: 23983166
[TBL] [Abstract][Full Text] [Related]
13. A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes.
Oelschlaegel U; Besson I; Arnoulet C; Sainty D; Nowak R; Naumann R; Bux Y; Ehninger G
Clin Lab Haematol; 2001 Apr; 23(2):81-90. PubMed ID: 11488846
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic significance of measurement of the receptor for urokinase-type plasminogen activator on granulocytes and in plasma from patients with paroxysmal nocturnal hemoglobinuria.
Gao W; Wang Z; Bai X; Li Y; Ruan C
Int J Hematol; 2002 May; 75(4):434-9. PubMed ID: 12041678
[TBL] [Abstract][Full Text] [Related]
15. Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia.
Meletis J; Terpos E; Samarkos M; Meletis C; Apostolidou E; Komninaka V; Anargyrou K; Korovesis K; Mavrogianni D; Variami E; Viniou N; Konstantopoulos K
Hematology; 2002 Apr; 7(2):69-74. PubMed ID: 12186694
[TBL] [Abstract][Full Text] [Related]
16. Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders.
Meletis J; Terpos E; Samarkos M; Meletis C; Konstantopoulos K; Komninaka V; Apostolidou E; Benopoulou O; Korovesis K; Mavrogianni D; Variami E; Yataganas X; Loukopoulos D
Haematologia (Budap); 2001; 31(1):7-16. PubMed ID: 11345408
[TBL] [Abstract][Full Text] [Related]
17. The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon.
Asimakopoulos JV; Terpos E; Papageorgiou L; Kampouropoulou O; Christoulas D; Giakoumis A; Samarkos M; Vaiopoulos G; Konstantopoulos K; Angelopoulou MK; Vassilakopoulos TP; Meletis J
Med Sci Monit; 2014 Jan; 20():123-39. PubMed ID: 24463881
[TBL] [Abstract][Full Text] [Related]
18. Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia.
Voskaridou E; Terpos E; Spina G; Palermos J; Rahemtulla A; Loutradi A; Loukopoulos D
Br J Haematol; 2003 Nov; 123(4):730-7. PubMed ID: 14616979
[TBL] [Abstract][Full Text] [Related]
19. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.
Wang SA; Pozdnyakova O; Jorgensen JL; Medeiros LJ; Stachurski D; Anderson M; Raza A; Woda BA
Haematologica; 2009 Jan; 94(1):29-37. PubMed ID: 19001281
[TBL] [Abstract][Full Text] [Related]
20. PNH revisited: Clinical profile, laboratory diagnosis and follow-up.
Gupta PK; Charan VD; Kumar H
Indian J Pathol Microbiol; 2009; 52(1):38-41. PubMed ID: 19136777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
